FGF21 Cancer Research Results
FGF21, FGF21: Click to Expand ⟱
| Source: |
| Type: |
Fibroblast Growth Factor 21 (FGF21). FGF21 is best known as a metabolic regulator involved in energy homeostasis.
– FGF21 is an endocrine member of the fibroblast growth factor family primarily secreted by the liver, but also produced by adipose tissue and skeletal muscle.
|
Scientific Papers found: Click to Expand⟱
TumCG↓, TumCP↓, Apoptosis↓, OS↑, H3K9↓, SUV39H↓, eff↑, CSCs↓, SOX9↓, HGF/c-Met↓, FGF21↓, EGFR↓, PDGFR-BB↓, Wnt↓, MYCN↑, OLIG2↓, AURKB↓, HO-1↑, P21↑,
*OS↑, *mt-ROS↓, *H2S↑, *FGF21↑, *cognitive↑, *GutMicro↑, *IGF-1↓, *mTOR↓, *GSH↑, *SOD↑, *MDA↓, *NRF2↑, *HO-1↑, *NQO1↑, *GLUT4↑, *Glycolysis↑, *HK2↑, *PFK↑, *PKM2↑, *GlucoseCon↑, *ATF4↑, *PPARα↑, GSH↓, GSTs↑, ROS↑, *neuroP↑,
*adiP↑, *FGF↑, *Insulin↓, *glucose↓, *Akt↑, *GSH↓, *PTEN↓, *FGF21↑, *PIP3↑,
Weight↓, TumVol↓, P21↑, p27↑, *adiP↑, *glucose↓, *IGF-1↓, *FGF21↑, *OS↑, Ki-67↓, Casp3↑, cycD1/CCND1↓,
AntiTum↑, PI3K↓, Akt↓, *AntiAge↑, *SIRT1↑, *lipid-P↓, *ROS↓, *BioAv↓, *NRF2↑, *HO-1↑, SOD↑, HDAC1↓, PTEN↑, P53↑, TumCCA↑, TumCI↓, TumMeta↓, EMT↓, MMPs↓, MMP9↓, angioG↓, VEGF↓, EGFR↓, FGF21↓, HIF-1↓, *neuroP↑, *cardioP↑, BMPs↑, ROS↑, Vim↓, N-cadherin↓, MMP3↓, MMP13↓, E-cadherin↑, Ki-67↓,
Showing Research Papers: 1 to 5 of 5
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 5
Pathway results for Effect on Cancer / Diseased Cells:
NA, unassigned(tgid=0) ⓘ
AURKB↓, 1, H3K9↓, 1, MYCN↑, 1, OLIG2↓, 1, SUV39H↓, 1,
Redox & Oxidative Stress(tgid=1) ⓘ
GSH↓, 1, GSTs↑, 1, HO-1↑, 1, ROS↑, 2, SOD↑, 1,
Core Metabolism/Glycolysis(tgid=4) ⓘ
FGF21↓, 2,
Cell Death(tgid=5) ⓘ
Akt↓, 1, Apoptosis↓, 1, Casp3↑, 1, HGF/c-Met↓, 1, p27↑, 1,
Kinase & Signal Transduction(tgid=6) ⓘ
SOX9↓, 1,
DNA Damage & Repair(tgid=10) ⓘ
P53↑, 1,
Cell Cycle & Senescence(tgid=11) ⓘ
cycD1/CCND1↓, 1, P21↑, 2, TumCCA↑, 1,
Proliferation, Differentiation & Cell State(tgid=12) ⓘ
CSCs↓, 1, EMT↓, 1, HDAC1↓, 1, PI3K↓, 1, PTEN↑, 1, TumCG↓, 1, Wnt↓, 1,
Migration(tgid=13) ⓘ
E-cadherin↑, 1, Ki-67↓, 2, MMP13↓, 1, MMP3↓, 1, MMP9↓, 1, MMPs↓, 1, N-cadherin↓, 1, TumCI↓, 1, TumCP↓, 1, TumMeta↓, 1, Vim↓, 1,
Angiogenesis & Vasculature(tgid=14) ⓘ
angioG↓, 1, EGFR↓, 2, HIF-1↓, 1, PDGFR-BB↓, 1, VEGF↓, 1,
Drug Metabolism & Resistance(tgid=21) ⓘ
eff↑, 1,
Clinical Biomarkers(tgid=22) ⓘ
BMPs↑, 1, EGFR↓, 2, Ki-67↓, 2,
Functional Outcomes(tgid=23) ⓘ
AntiTum↑, 1, OS↑, 1, TumVol↓, 1, Weight↓, 1,
Total Targets: 52
Pathway results for Effect on Normal Cells:
Redox & Oxidative Stress(tgid=1) ⓘ
GSH↓, 1, GSH↑, 1, HO-1↑, 2, lipid-P↓, 1, MDA↓, 1, NQO1↑, 1, NRF2↑, 2, ROS↓, 1, mt-ROS↓, 1, SOD↑, 1,
Mitochondria & Bioenergetics(tgid=3) ⓘ
Insulin↓, 1,
Core Metabolism/Glycolysis(tgid=4) ⓘ
adiP↑, 2, FGF21↑, 3, glucose↓, 2, GlucoseCon↑, 1, Glycolysis↑, 1, H2S↑, 1, HK2↑, 1, PFK↑, 1, PIP3↑, 1, PKM2↑, 1, PPARα↑, 1, SIRT1↑, 1,
Cell Death(tgid=5) ⓘ
Akt↑, 1,
Proliferation, Differentiation & Cell State(tgid=12) ⓘ
FGF↑, 1, IGF-1↓, 2, mTOR↓, 1, PTEN↓, 1,
Angiogenesis & Vasculature(tgid=14) ⓘ
ATF4↑, 1,
Barriers & Transport(tgid=15) ⓘ
GLUT4↑, 1,
Drug Metabolism & Resistance(tgid=21) ⓘ
BioAv↓, 1,
Clinical Biomarkers(tgid=22) ⓘ
GutMicro↑, 1,
Functional Outcomes(tgid=23) ⓘ
AntiAge↑, 1, cardioP↑, 1, cognitive↑, 1, neuroP↑, 2, OS↑, 2,
Total Targets: 37
Scientific Paper Hit Count for: FGF21, FGF21
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:% Target#:1279 State#:% Dir#:%
wNotes=0 sortOrder:rid,rpid
Home Page